[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370236-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370236-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","e2f1-activates-breast-stromal-fibroblasts-and-promotes-their-paracrine-pro-carcinogenic-effects","E2F1 activates breast stromal fibroblasts and promotes their paracrine pro-carcinogenic effects","","Breast tumors depend on a tumor microenvironment rich in cancer-associated fibroblasts (CAFs), which drive carcinogenesis through paracrine signaling. This study examines the transcription factor E2F1 in the active status of CAFs. CAFs show higher E2F1 than adjacent tumor counterpart fibroblasts, and E2F1 overexpression activates quiescent breast stromal fibroblasts, enhancing EMT and stemness in vitro and in vivo. E2F1 knockdown normalizes CAFs, reduces pro-carcinogenic paracrine effects, and modulates chemotherapeutic resistance, suggesting E2F1 as a precision therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/e2f1-activates-breast-stromal-fibroblasts-and-promotes-their-paracrine-pro-carcinogenic-effects/370236/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/e2f1-activates-breast-stromal-fibroblasts-and-promotes-their-paracrine-pro-carcinogenic-effects/370236.png","ImageObject",300,407,{"name":42,"@type":43},"Eliana","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does E2F1 play in active cancer-associated fibroblasts (CAFs)?","Question",{"text":63,"@type":64},"CAFs express higher E2F1 than adjacent tumor counterpart fibroblasts, and E2F1 upregulation activates quiescent breast stromal fibroblasts.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does E2F1 activation affect breast cancer cells?",{"text":68,"@type":64},"E2F1-expressing fibroblasts enhance epithelial-to-mesenchymal transition (EMT) and stemness processes in breast cancer cells in vitro and in vivo.",{"name":70,"@type":61,"acceptedAnswer":71},"What is the effect of E2F1 knockdown on CAFs and therapy response?",{"text":72,"@type":64},"E2F1 knockdown normalizes breast CAFs and suppresses their paracrine pro-carcinogenic effects, and E2F1-deficient fibroblasts increase sensitivity to cisplatin.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370236,1790197919,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nE2F1 activates breast stromal fibroblasts and promotes their paracrine pro-carcinogenic effects  \nLayla A. Al-Kharashi1,2, Falah H. Al-Mohanna3, Abdelilah Aboussekhra1􀀍 & Abdelilah Abousekhra1  \nBreast cancers (BC) are complex neo-organs composed of neoplastic as well as non-carcinogenic cells, in addition to a dynamic extracellular matrix. Active cancer-associated fibroblasts (CAFs) play major roles in the development and spread of breast cancers, through paracrine signaling, which are under the control of several transcription regulators. In the present study, we investigated the role of the transcription factor E2F1 in the active status of CAFs. We have shown that CAFs express higher levels of E2F1 compared to their adjacent tumor counterpart fibroblasts (TCFs) . Importantly, E2F1 upregulation by ectopic expression transactivated quiescent breast stromal fibroblasts and promoted their paracrine pro-carcinogenic effects. Indeed, E2F1-expressing fibroblasts were more efficient than their corresponding controls in enhancing the epithelial-to-mesenchymal transition and stemness processes in breast cancer cells both in vitro and in vivo. However, E2F1 knock-down normalized breast CAFs and suppressed their paracrine pro-carcinogenic effects. Interestingly, while fibroblasts expressing high level of E2F1 enhanced the resistance of BC cells to chemotherapeutic drugs, E2F1-deficient fibroblasts enhanced their sensitivity to cisplatin. Together, these findings indicate that the transciption factor E2F1 plays a critical role in the transactivation of breast stromal fibroblasts, and therefore could be a great therapeutic target for precision therapeutics of BC patients.  \nKeywords Breast cancer, Cancer-associated fibroblasts, Cancer stem cells, E2F1, EMT  \nAbbreviations  \nATCC American type culture collection CAFs Cancer-associated fibroblasts  \nCSCs Cancer stem cells  \nDMSO Dimethyl sulfoxide  \nEMT Epithelial-to-mesenchymal transition GAPDH Glyceraldehyde-3-phosphate dehydrogenase NBFs Normal breast fibroblasts  \nPBS phosphate buffered saline  \nIt has become clear that the tumor microenvironment (TME) in breast tumors is predominantly composed offibroblasts named cancer-associated fibroblasts (CAFs)1. When active, these cells promote carcinogenesis through paracrine signaling mediated by the secretion of various cancer-promoting molecules such as SDF-1, IL-6 and TGF-β2. The expression of these proteins is under the control of several transcription factors such as NF-κB and STAT3, which play key roles in the transactivation of normal breast fibroblasts (NBFs) to active CAFs1,3. CAFs exhibit high heterogeneity and plasticity, which enable cancer cells invasion and metastasis1,4. Furthermore, numerous studies have shown CAF-related resistance to chemotherapy, radiotherapy, immunotherapy, and hormone therapy, which revealed promising avenues for targeting CAFs and their paracrine effects on tumor cells as efficient therapeutic possibilities2,5,6.  \nE2F transcription factor1 (E2F1) is one of the founding members of the E2F family of transcription factors. It plays a major role in cell cycle regulation, cell differentiation, DNA repair, and apoptosis7,8. Several lines of evidence have associated the E2F1 transcription factor with several types of cancer, including BC. Indeed, E2F1 has been found to be highly expressed in advanced breast cancer tissues, which correlated with poor  \n1Department of Molecular Oncology, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Kingdom of Saudi Arabia. 2Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Kingdom of Saudi Arabia. 3Department of Comparative Medicine, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Kingdom of Saudi Arabia. 􀀍 email: [aboussekhra@kfshrc.edu.sa](aboussekhra@kfshrc.edu.sa)  \n[www. nature.com/scientific","cbCaiu7hZLg8VLTD","https://ap.wps.com/l/cbCaiu7hZLg8VLTD","pdf",5225954,13,"English","# Introduction\n## Tumor microenvironment and CAF-mediated signaling\n## E2F1 and its links to breast cancer\n# Materials and Methods\n## Cells and cell culture\n## Cellular lysate preparation and immunoblotting","[{\"question\":\"What role does E2F1 play in active cancer-associated fibroblasts (CAFs)?\",\"answer\":\"CAFs express higher E2F1 than adjacent tumor counterpart fibroblasts, and E2F1 upregulation activates quiescent breast stromal fibroblasts.\"},{\"question\":\"How does E2F1 activation affect breast cancer cells?\",\"answer\":\"E2F1-expressing fibroblasts enhance epithelial-to-mesenchymal transition (EMT) and stemness processes in breast cancer cells in vitro and in vivo.\"},{\"question\":\"What is the effect of E2F1 knockdown on CAFs and therapy response?\",\"answer\":\"E2F1 knockdown normalizes breast CAFs and suppresses their paracrine pro-carcinogenic effects, and E2F1-deficient fibroblasts increase sensitivity to cisplatin.\"}]","E2F1 activates breast stromal fibroblasts and promotes their paracrine pro-carcinogenic effects | PDF",1790187554,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7a09d766189f058bf1a6d5fce19f8097.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e988016af7b4c41c51aeef618b060be1.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bc0fb97ba3a13b7f05cb69265a1e695c.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1090579fa9803bec011afa9a4f156926.webp",980,1287]